Evidence map›Paper›PMID 27481234›Full record

ArticleCellular and molecular neurobiology2017

The Anticonvulsant and Neuroprotective Effects of Oxysophocarpine on Pilocarpine-Induced Convulsions in Adult Male Mice.

Gang Liu, Jing Wang, Xian-Hua Deng, Peng-Sheng Ma, Feng-Mei Li, Xiao-Dong Peng, Yang Niu, Tao Sun, Yu-Xiang Li, Jian-Qiang Yu

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Five percent CONeuroprotection (Chichester, England) · 2024
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Gang LiuDepartment of Pharmacology, Ningxia Medical University, Yinchuan, 750004, China.
Jing WangDepartment of Pharmacology, Ningxia Medical University, Yinchuan, 750004, China.
Xian-Hua DengDepartment of Pharmacology, Ningxia Medical University, Yinchuan, 750004, China.
Peng-Sheng MaDepartment of Pharmacology, Ningxia Medical University, Yinchuan, 750004, China.
Feng-Mei LiDepartment of Pharmacology, Ningxia Medical University, Yinchuan, 750004, China.
Xiao-Dong PengDepartment of Pharmacology, Ningxia Medical University, Yinchuan, 750004, China.
Yang NiuKey Laboratory of Hui Ethnic Medicine Modernization, Ministry of Education, Ningxia Medical University, Yinchuan, 750004, China.
Tao SunNingxia Key Laboratory of Craniocerebral Diseases of Ningxia Hui Autonomous Region, Ningxia Medical University, Yinchuan, 750004, China.
Yu-Xiang LiCollege of Nursing, Ningxia Medical University, Yinchuan, 750004, China. li_yuxiang@163.com.
Jian-Qiang YuDepartment of Pharmacology, Ningxia Medical University, Yinchuan, 750004, China. yujq910315@163.com.
Ningxia Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epilepsy is one of the prevalent and major neurological disorders, and approximately one-third of the individuals with epilepsy experience seizures that do not respond well to available medications. We investigated whether oxysophocarpine (OSC) had anticonvulsant and neuroprotective property in the pilocarpine (PILO)-treated mice. Thirty minutes prior to the PILO injection, the mice were administrated with OSC (20, 40, and 80 mg/kg) once. Seizures and electroencephalography (EEG) were observed, and then the mice were killed for Nissl and Fluoro-jade B (FJB) staining. The oxidative stress was measured at 24 h after convulsion. Western blot analysis was used to examine the expressions of the Bax, Bcl-2, and Caspase-3. In this study, we found that pretreatment with OSC (40, 80 mg/kg) significantly delayed the onset of the first convulsion and status epilepticus (SE) and reduced the incidence of SE and mortality. Analysis of EEG recordings revealed that OSC (40, 80 mg/kg) significantly reduced epileptiform discharges. Furthermore, Nissl and FJB staining showed that OSC (40, 80 mg/kg) attenuated the neuronal cell loss and degeneration in hippocampus. In addition, OSC (40, 80 mg/kg) attenuated the changes in the levels of Malondialdehyde (MDA) and strengthened glutathione peroxidase and catalase activity in the hippocampus. Western blot analysis showed that OSC (40, 80 mg/kg) significantly decreased the expressions of Bax, Caspase-3 and increased the expression of Bcl-2. Collectively, the findings of this study indicated that OSC exerted anticonvulsant and neuroprotective effects on PILO-treated mice. The beneficial effects should encourage further studies to investigate OSC as an adjuvant in epilepsy, both to prevent seizures and to protect neurons in brain.

Indexed as

Age FactorsAlkaloidsAnimalsAnticonvulsantsDose-Response Relationship, DrugMaleMatrinesMiceMice, Inbred ICRNeuroprotective AgentsOxidative StressPilocarpineSeizuresTreatment OutcomeAlkaloidsAnticonvulsantsMatrinesNeuroprotective AgentsoxysophocarpinePilocarpineAnticonvulsantConvulsionNeuronal damageNeuroprotectionOxysophocarpinePilocarpine

Identifiers

PMID27481234
PMCPMC11482216
OpenAlexW2482468021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.